Position in AMGN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$883,934
+$169,327 QoQ
Shares Held
2,441
+20.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,782
of 3,140 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KANAWHA CAPITAL MANAGEMENT LLC holds $95,466,643 across 8 Drug Manufacturers - General names. AMGN ranks #7 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
148,501 | $37,714,798 | |
| 2 | ABBV |
AbbVie Inc.
|
141,643 | $35,643,044 | |
| 3 | LLY |
ELI LILLY & Co
|
8,046 | $9,650,614 | |
| 4 | PFE |
Pfizer Inc
|
290,647 | $6,998,779 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
40,741 | $2,347,496 | |
| 6 | MRK |
Merck & Co., Inc.
|
12,938 | $1,662,533 | |
| 7 | AMGN |
Amgen Inc
This page
|
2,441 | $883,934 | |
| 8 | NVS |
Novartis AG
|
3,608 | $565,445 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $883,934 | 2,441 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $714,607 | 2,031 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $637,599 | 1,948 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $371,093 | 1,315 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $326,675 | 1,170 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $306,565 | 984 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $239,267 | 918 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $295,788 | 918 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $278,392 | 891 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $480,785 | 1,691 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $256,625 | 891 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $239,465 | 891 | Shares | Sole | 2023-10-26 | |
| 2023-03-31 | $213,948 | 885 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $392,646 | 1,495 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $314,658 | 1,396 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $314,100 | 1,291 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $310,496 | 1,284 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $286,611 | 1,274 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $281,548 | 1,324 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $322,481 | 1,323 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $329,175 | 1,323 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $303,494 | 1,320 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $358,619 | 1,411 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $324,307 | 1,375 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $278,753 | 1,375 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||